tradingkey.logo


tradingkey.logo


Pacific Biosciences of California Inc

PACB
1.260USD
0.0000.00%
終倀 03/30, 16:00ET15分遅れの株䟡
70.03M時䟡総額
損倱額盎近12ヶ月PER


Pacific Biosciences of California Inc

1.260
0.0000.00%

詳现情報 Pacific Biosciences of California Inc 䌁業名

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Pacific Biosciences of California Incの䌁業情報


䌁業コヌドPACB
䌚瀟名Pacific Biosciences of California Inc
䞊堎日Oct 27, 2010
最高経営責任者「CEO」Henry (Christian O)
埓業員数575
蚌刞皮類Ordinary Share
決算期末Oct 27
本瀟所圚地1305 O'brien Drive
郜垂MENLO PARK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94025
電話番号16505218000
りェブサむトhttps://www.pacb.com/
䌁業コヌドPACB
䞊堎日Oct 27, 2010
最高経営責任者「CEO」Henry (Christian O)

Pacific Biosciences of California Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.13M
-1.10%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-20.75%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-20.75%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Mr. Bill Ericson ,J.D.
Mr. Bill Ericson ,J.D.
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.13M
-1.10%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-20.75%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-20.75%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Mr. Bill Ericson ,J.D.
Mr. Bill Ericson ,J.D.
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Consumable revenue
21.28M
55.35%
Instrument revenue
11.32M
29.44%
Service And Other
5.84M
15.20%
地域別USD
䌚瀟名
収益
比率
North America
18.10M
47.08%
Europe (including the Middle East and Africa)
10.75M
27.97%
Asia Pacific
9.59M
24.95%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Consumable revenue
21.28M
55.35%
Instrument revenue
11.32M
29.44%
Service And Other
5.84M
15.20%

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
ARK Investment Management LLC
12.34%
SoftBank Group Corp
6.77%
BlackRock Institutional Trust Company, N.A.
6.72%
The Vanguard Group, Inc.
5.64%
Amova Asset Management Co., Ltd.
2.59%
他の
65.94%
株䞻統蚈
株䞻統蚈
比率
ARK Investment Management LLC
12.34%
SoftBank Group Corp
6.77%
BlackRock Institutional Trust Company, N.A.
6.72%
The Vanguard Group, Inc.
5.64%
Amova Asset Management Co., Ltd.
2.59%
他の
65.94%
皮類
株䞻統蚈
比率
Investment Advisor
36.56%
Investment Advisor/Hedge Fund
10.69%
Hedge Fund
9.28%
Holding Company
6.77%
Research Firm
2.56%
Individual Investor
1.55%
Corporation
1.16%
Venture Capital
0.21%
Bank and Trust
0.18%
他の
31.04%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
549
169.06M
56.00%
-65.22M
2025Q3
566
166.98M
55.32%
-97.69M
2025Q2
600
214.62M
71.52%
-110.62M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
ARK Investment Management LLC
30.92M
10.24%
-5.37M
-14.81%
Sep 30, 2025
SoftBank Group Corp
20.45M
6.77%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
19.86M
6.58%
-103.12K
-0.52%
Sep 30, 2025
The Vanguard Group, Inc.
16.38M
5.43%
+362.80K
+2.27%
Sep 30, 2025
Amova Asset Management Co., Ltd.
8.68M
2.87%
-540.90K
-5.87%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.91M
2.29%
+187.78K
+2.79%
Sep 30, 2025
State Street Investment Management (US)
5.91M
1.96%
+155.06K
+2.69%
Sep 30, 2025
Millennium Management LLC
4.92M
1.63%
+4.05M
+466.29%
Sep 30, 2025
Point72 (DIFC) Ltd
4.27M
1.41%
+1.81M
+73.65%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
ARK Genomic Revolution ETF
2.3%
iShares Genomics Immunology and Healthcare ETF
1.31%
Invesco NASDAQ Future Gen 200 ETF
0.96%
Global X Genomics & Biotechnology ETF
0.69%
ARK Innovation ETF
0.58%
AXS Green Alpha ETF
0.58%
WisdomTree BioRevolution Fund
0.48%
Invesco RAFI US 1500 Small-Mid ETF
0.09%
ProShares Ultra Nasdaq Biotechnology
0.08%
Invesco Nasdaq Biotechnology ETF
0.07%
詳现を芋る
ARK Genomic Revolution ETF
比率2.3%
iShares Genomics Immunology and Healthcare ETF
比率1.31%
Invesco NASDAQ Future Gen 200 ETF
比率0.96%
Global X Genomics & Biotechnology ETF
比率0.69%
ARK Innovation ETF
比率0.58%
AXS Green Alpha ETF
比率0.58%
WisdomTree BioRevolution Fund
比率0.48%
Invesco RAFI US 1500 Small-Mid ETF
比率0.09%
ProShares Ultra Nasdaq Biotechnology
比率0.08%
Invesco Nasdaq Biotechnology ETF
比率0.07%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™